A  ||| S:0 E:2 ||| DT
study  ||| S:2 E:8 ||| NN
of  ||| S:8 E:11 ||| IN
implanted  ||| S:11 E:21 ||| FW
cardiac  ||| S:21 E:29 ||| FW
rhythm  ||| S:29 E:36 ||| FW
recorders  ||| S:36 E:46 ||| FW
in  ||| S:46 E:49 ||| FW
advanced  ||| S:49 E:58 ||| FW
cardiac  ||| S:58 E:66 ||| FW
AL  ||| S:66 E:69 ||| FW
amyloidosis  ||| S:69 E:81 ||| FW
AL  ||| S:81 E:84 ||| FW
amyloidosis  ||| S:84 E:96 ||| FW
may  ||| S:96 E:100 ||| MD
respond  ||| S:100 E:108 ||| VB
to  ||| S:108 E:111 ||| TO
chemotherapy  ||| S:111 E:124 ||| VB
but  ||| S:124 E:128 ||| CC
two-thirds  ||| S:128 E:139 ||| NNS
of  ||| S:139 E:142 ||| IN
patients  ||| S:142 E:151 ||| NNS
with  ||| S:151 E:156 ||| IN
severe  ||| S:156 E:163 ||| JJ
cardiac  ||| S:163 E:171 ||| JJ
involvement  ||| S:171 E:183 ||| NN
die  ||| S:183 E:187 ||| NN
within  ||| S:187 E:194 ||| IN
a  ||| S:194 E:196 ||| DT
year  ||| S:196 E:201 ||| NN
of  ||| S:201 E:204 ||| IN
diagnosis ||| S:204 E:213 ||| NN
,  ||| S:213 E:215 ||| ,
purportedly  ||| S:215 E:227 ||| VBG
from  ||| S:227 E:232 ||| IN
tachyarrhythmias  ||| S:232 E:249 ||| NN
or  ||| S:249 E:252 ||| CC
electromechanical  ||| S:252 E:270 ||| JJ
dissociation ||| S:270 E:282 ||| NN
.  ||| S:282 E:284 ||| .
We  ||| S:284 E:287 ||| PRP
sought  ||| S:287 E:294 ||| VBD
to  ||| S:294 E:297 ||| TO
characterize  ||| S:297 E:310 ||| VB
the  ||| S:310 E:314 ||| DT
nature  ||| S:314 E:321 ||| NN
of  ||| S:321 E:324 ||| IN
cardiac  ||| S:324 E:332 ||| JJ
arrhythmias  ||| S:332 E:344 ||| NN
in  ||| S:344 E:347 ||| IN
severe  ||| S:347 E:354 ||| JJ
cardiac  ||| S:354 E:362 ||| JJ
AL  ||| S:362 E:365 ||| NNS
amyloidosis  ||| S:365 E:377 ||| VBP
using  ||| S:377 E:383 ||| VBG
implanted  ||| S:383 E:393 ||| JJ
cardiac  ||| S:393 E:401 ||| JJ
rhythm  ||| S:401 E:408 ||| NN
recorders ||| S:408 E:417 ||| NNS
.  ||| S:417 E:419 ||| .
Implantable  ||| S:419 E:431 ||| JJ
loop  ||| S:431 E:436 ||| NN
recorders  ||| S:436 E:446 ||| NNS
( ||| S:446 E:447 ||| -LRB-
ILRs ||| S:447 E:451 ||| NNP
)  ||| S:451 E:453 ||| -RRB-
were  ||| S:453 E:458 ||| VBD
inserted  ||| S:458 E:467 ||| VBN
within  ||| S:467 E:474 ||| IN
24  ||| S:474 E:477 ||| CD
h  ||| S:477 E:479 ||| NN
of  ||| S:479 E:482 ||| IN
baseline  ||| S:482 E:491 ||| JJ
evaluation  ||| S:491 E:502 ||| NN
at  ||| S:502 E:505 ||| IN
the  ||| S:505 E:509 ||| DT
UK  ||| S:509 E:512 ||| NNP
National  ||| S:512 E:521 ||| NNP
Amyloidosis  ||| S:521 E:533 ||| NNP
Centre ||| S:533 E:539 ||| NNP
,  ||| S:539 E:541 ||| ,
into  ||| S:541 E:546 ||| IN
20  ||| S:546 E:549 ||| CD
consecutive  ||| S:549 E:561 ||| JJ
patients  ||| S:561 E:570 ||| NNS
with  ||| S:570 E:575 ||| IN
newly  ||| S:575 E:581 ||| RB
diagnosed  ||| S:581 E:591 ||| VBN
severe  ||| S:591 E:598 ||| JJ
cardiac  ||| S:598 E:606 ||| JJ
AL  ||| S:606 E:609 ||| NNP
amyloidosis  ||| S:609 E:621 ||| NN
and  ||| S:621 E:625 ||| CC
symptoms  ||| S:625 E:634 ||| NNS
of  ||| S:634 E:637 ||| IN
syncope  ||| S:637 E:645 ||| NN
or  ||| S:645 E:648 ||| CC
pre-syncope ||| S:648 E:659 ||| JJ
.  ||| S:659 E:661 ||| .
Weekly  ||| S:661 E:668 ||| NNP
ILR  ||| S:668 E:672 ||| NNP
recordings  ||| S:672 E:683 ||| NNS
and  ||| S:683 E:687 ||| CC
additional  ||| S:687 E:698 ||| JJ
recordings  ||| S:698 E:709 ||| NNS
at  ||| S:709 E:712 ||| IN
the  ||| S:712 E:716 ||| DT
time  ||| S:716 E:721 ||| NN
of  ||| S:721 E:724 ||| IN
symptoms  ||| S:724 E:733 ||| NNS
were  ||| S:733 E:738 ||| VBD
obtained ||| S:738 E:746 ||| VBN
.  ||| S:746 E:748 ||| .
Median  ||| S:748 E:755 ||| NNP
( ||| S:755 E:756 ||| -LRB-
range ||| S:756 E:761 ||| NN
)  ||| S:761 E:763 ||| -RRB-
follow-up  ||| S:763 E:773 ||| JJ
from  ||| S:773 E:778 ||| IN
baseline  ||| S:778 E:787 ||| NN
was  ||| S:787 E:791 ||| VBD
308  ||| S:791 E:795 ||| CD
( ||| S:795 E:796 ||| -LRB-
10-399 ||| S:796 E:802 ||| NNP
)  ||| S:802 E:804 ||| -RRB-
days ||| S:804 E:808 ||| NNS
.  ||| S:808 E:810 ||| .
Thirteen  ||| S:810 E:819 ||| JJ
patients  ||| S:819 E:828 ||| NNS
died ||| S:828 E:832 ||| VBD
,  ||| S:832 E:834 ||| ,
and  ||| S:834 E:838 ||| CC
median  ||| S:838 E:845 ||| JJ
survival  ||| S:845 E:854 ||| NN
in  ||| S:854 E:857 ||| IN
the  ||| S:857 E:861 ||| DT
whole  ||| S:861 E:867 ||| JJ
cohort  ||| S:867 E:874 ||| NN
was  ||| S:874 E:878 ||| VBD
61  ||| S:878 E:881 ||| CD
days  ||| S:881 E:886 ||| NNS
from  ||| S:886 E:891 ||| IN
device  ||| S:891 E:898 ||| NN
insertion ||| S:898 E:907 ||| NN
.  ||| S:907 E:909 ||| .
In  ||| S:909 E:912 ||| IN
each  ||| S:912 E:917 ||| DT
of  ||| S:917 E:920 ||| IN
eight  ||| S:920 E:926 ||| CD
evaluable  ||| S:926 E:936 ||| CD
cases ||| S:936 E:941 ||| NNS
,  ||| S:941 E:943 ||| ,
death  ||| S:943 E:949 ||| NN
was  ||| S:949 E:953 ||| VBD
heralded  ||| S:953 E:962 ||| VBN
by  ||| S:962 E:965 ||| IN
bradycardia ||| S:965 E:976 ||| NN
,  ||| S:976 E:978 ||| ,
usually  ||| S:978 E:986 ||| RB
associated  ||| S:986 E:997 ||| VBN
with  ||| S:997 E:1002 ||| IN
complete  ||| S:1002 E:1011 ||| JJ
atrioventricular  ||| S:1011 E:1028 ||| JJ
block  ||| S:1028 E:1034 ||| NN
( ||| S:1034 E:1035 ||| -LRB-
CAVB ||| S:1035 E:1039 ||| NNP
) ||| S:1039 E:1040 ||| -RRB-
,  ||| S:1040 E:1042 ||| ,
followed  ||| S:1042 E:1051 ||| VBD
shortly  ||| S:1051 E:1059 ||| RB
thereafter  ||| S:1059 E:1070 ||| RB
by  ||| S:1070 E:1073 ||| IN
pulseless  ||| S:1073 E:1083 ||| JJ
electrical  ||| S:1083 E:1094 ||| JJ
activity ||| S:1094 E:1102 ||| NN
.  ||| S:1102 E:1104 ||| .
Four  ||| S:1104 E:1109 ||| CD
patients  ||| S:1109 E:1118 ||| NNS
received  ||| S:1118 E:1127 ||| VBD
pacemakers ||| S:1127 E:1137 ||| NNS
,  ||| S:1137 E:1139 ||| ,
a  ||| S:1139 E:1141 ||| DT
median  ||| S:1141 E:1148 ||| JJ
( ||| S:1148 E:1149 ||| -LRB-
range ||| S:1149 E:1154 ||| NN
)  ||| S:1154 E:1156 ||| -RRB-
of  ||| S:1156 E:1159 ||| IN
7  ||| S:1159 E:1161 ||| CD
( ||| S:1161 E:1162 ||| -LRB-
3-38 ||| S:1162 E:1166 ||| NNP
)  ||| S:1166 E:1168 ||| -RRB-
h  ||| S:1168 E:1170 ||| NN
after  ||| S:1170 E:1176 ||| IN
development  ||| S:1176 E:1188 ||| NN
of  ||| S:1188 E:1191 ||| IN
symptomatic  ||| S:1191 E:1203 ||| JJ
CAVB ||| S:1203 E:1207 ||| NNP
,  ||| S:1207 E:1209 ||| ,
but  ||| S:1209 E:1213 ||| CC
these  ||| S:1213 E:1219 ||| DT
did  ||| S:1219 E:1223 ||| VBD
not  ||| S:1223 E:1227 ||| RB
prevent  ||| S:1227 E:1235 ||| VB
rapid  ||| S:1235 E:1241 ||| JJ
cardiac  ||| S:1241 E:1249 ||| JJ
decompensation  ||| S:1249 E:1264 ||| NN
and  ||| S:1264 E:1268 ||| CC
death  ||| S:1268 E:1274 ||| NN
in  ||| S:1274 E:1277 ||| IN
three  ||| S:1277 E:1283 ||| CD
cases ||| S:1283 E:1288 ||| NNS
.  ||| S:1288 E:1290 ||| .
Despite  ||| S:1290 E:1298 ||| IN
272  ||| S:1298 E:1302 ||| CD
loop  ||| S:1302 E:1307 ||| CD
recordings ||| S:1307 E:1317 ||| NNS
,  ||| S:1317 E:1319 ||| ,
there  ||| S:1319 E:1325 ||| EX
was  ||| S:1325 E:1329 ||| VBD
only  ||| S:1329 E:1334 ||| RB
one  ||| S:1334 E:1338 ||| CD
episode  ||| S:1338 E:1346 ||| NN
of  ||| S:1346 E:1349 ||| IN
non-sustained  ||| S:1349 E:1363 ||| JJ
ventricular  ||| S:1363 E:1375 ||| JJ
tachycardia ||| S:1375 E:1386 ||| NN
,  ||| S:1386 E:1388 ||| ,
which  ||| S:1388 E:1394 ||| WDT
was  ||| S:1394 E:1398 ||| VBD
preceded  ||| S:1398 E:1407 ||| VBN
by  ||| S:1407 E:1410 ||| IN
severe  ||| S:1410 E:1417 ||| JJ
bradycardia ||| S:1417 E:1428 ||| NN
.  ||| S:1428 E:1430 ||| .
Patients  ||| S:1430 E:1439 ||| NNS
who  ||| S:1439 E:1443 ||| WP
died  ||| S:1443 E:1448 ||| VBD
had  ||| S:1448 E:1452 ||| VBN
significantly  ||| S:1452 E:1466 ||| RB
worse  ||| S:1466 E:1472 ||| RBR
global  ||| S:1472 E:1479 ||| JJ
left  ||| S:1479 E:1484 ||| JJ
ventricular  ||| S:1484 E:1496 ||| JJ
strain  ||| S:1496 E:1503 ||| NN
on  ||| S:1503 E:1506 ||| IN
echocardiography  ||| S:1506 E:1523 ||| NNS
( ||| S:1523 E:1524 ||| -LRB-
P  ||| S:1524 E:1526 ||| NN
=  ||| S:1526 E:1528 ||| SYM
0.029 ||| S:1528 E:1533 ||| CD
)  ||| S:1533 E:1535 ||| -RRB-
and  ||| S:1535 E:1539 ||| CC
reduced  ||| S:1539 E:1547 ||| VBD
6  ||| S:1547 E:1549 ||| CD
min  ||| S:1549 E:1553 ||| NNS
walk  ||| S:1553 E:1558 ||| VBP
distance  ||| S:1558 E:1567 ||| NN
( ||| S:1567 E:1568 ||| -LRB-
P  ||| S:1568 E:1570 ||| NN
=  ||| S:1570 E:1572 ||| SYM
0.048 ||| S:1572 E:1577 ||| CD
)  ||| S:1577 E:1579 ||| -RRB-
at  ||| S:1579 E:1582 ||| IN
baseline  ||| S:1582 E:1591 ||| NN
compared  ||| S:1591 E:1600 ||| VBN
with  ||| S:1600 E:1605 ||| IN
survivors ||| S:1605 E:1614 ||| NNS
.  ||| S:1614 E:1616 ||| .
The  ||| S:1616 E:1620 ||| DT
discovery  ||| S:1620 E:1630 ||| NN
that  ||| S:1630 E:1635 ||| WDT
bradyarrhythmias  ||| S:1635 E:1652 ||| VBZ
heralded  ||| S:1652 E:1661 ||| VBN
terminal  ||| S:1661 E:1670 ||| JJ
cardiac  ||| S:1670 E:1678 ||| JJ
decompensation  ||| S:1678 E:1693 ||| NN
in  ||| S:1693 E:1696 ||| IN
most  ||| S:1696 E:1701 ||| JJS
patients  ||| S:1701 E:1710 ||| NNS
with  ||| S:1710 E:1715 ||| IN
severe  ||| S:1715 E:1722 ||| JJ
cardiac  ||| S:1722 E:1730 ||| JJ
AL  ||| S:1730 E:1733 ||| NNP
amyloidosis  ||| S:1733 E:1745 ||| NN
supports  ||| S:1745 E:1754 ||| VBZ
a  ||| S:1754 E:1756 ||| DT
study  ||| S:1756 E:1762 ||| NN
of  ||| S:1762 E:1765 ||| IN
prophylactic  ||| S:1765 E:1778 ||| JJ
pacemaker  ||| S:1778 E:1788 ||| NN
insertion  ||| S:1788 E:1798 ||| NN
in  ||| S:1798 E:1801 ||| IN
this  ||| S:1801 E:1806 ||| DT
patient  ||| S:1806 E:1814 ||| JJ
population ||| S:1814 E:1824 ||| NN
.  ||| S:1824 E:1826 ||| .
